CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Cash flows from operating activities
Net loss	$ (1,200,940)	$ (5,368,482)	$ (5,489,892)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	(50,036)	45,297
Provision for employee advance reserve	4,715	(13,268)
Depreciation and amortization	127,211	114,874
Stock-based compensation	502,408	476,096
Warrants issued to 2012 private placement investors		487,200
Loss on extinguishment of notes and accounts payable		2,792,900
Imputed value of services contributed	116,667	262,500
Amortization of debt discount	182,766	125,163
Changes in operating assets and liabilities:
Accounts receivable	208,058	(100,240)
Inventories - finished goods	136,964	2,957
Prepaid expenses and other current assets	(12,982)	(30,133)
Accounts payable - trade	(371,735)	362,064
Accounts payable - related parties	(35,017)	174,321
Accrued expenses and other current liabilities	356,491	(251,615)
Deferred revenue	(91,671)	39,128
Net cash used in operating activities	(127,101)	(881,238)
Cash flows from investing activities
Change in restricted cash	(650,074)	850,002
Website development costs	(98,001)	(68,590)
Net cash (used in) and provided by investing activities	(748,075)	781,412
Cash flows from financing activities
Principal payments on equipment leases payable	(41,269)	(36,262)
Proceeds from issuance of notes payable	150,000	500,000
Repayment of notes payable and other advances - related parties	(5,000)	(2,017,905)
Repayment of convertible notes payable		(1,000,000)
Proceeds from the sale of common stock	1,208,759	2,651,973
Proceeds from notes payable and other advances - related parties		56,000
Net cash provided by financing activities	1,312,490	153,806
Net increase in cash	437,314	53,980
Cash - beginning of period	67,744
Cash - end of period	505,058	53,980	67,744
Interest	65,395	416,369
Income Taxes		899
Non-cash investing and financing activities:
Issuance of Series B preferred stock for settlement of accrued dividends	279,380	261,084
Cashless exercise of warrants into common stock		10,342
Warrants issued as debt discount in connection with notes payable	36,000	315,300
Accrual of contractual dividends on Series B convertible preferred stock	224,189	209,520
Deemed dividends on Series B convertible preferred stock		1,532,722
Common stock and warrants issued in exchange of notes and accounts payable		3,625,900
Conversion of accounts payable to notes payable		$ 40,000